GlassScriptPhysician profile
Arvind Rangarajan Murali
NPI 1073800181
$46,475.52
in general payments reported to CMS, 2019-2025
10 companies · $28K in 2025
The $28K reported for 2025 was more than what 79% of Hepatology providers received nationally (typical 2025 total: $981).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,360 · 2022: $2,700 · 2023: $370 · 2024: $13K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $37K · Consulting Fee: $3,128 · Food and Beverage: $1,195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $37,093.00 |
| Consulting Fee | $3,127.50 |
| Food and Beverage | $1,195.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Madrigal Pharmaceuticals | $38,680.69 | 2024-2025 | Rezdiffra |
| Takeda Pharmaceuticals U.S.A., INC. | $2,700.00 | 2022 | |
| Gilead Sciences, INC. | $2,360.00 | 2021 | |
| Intercept Pharmaceuticals, INC. | $2,160.00 | 2025 | |
| Boston Scientific Corporation | $224.71 | 2023 | Axios, Exalt Model D |
| Abbvie INC. | $126.55 | 2023-2025 | |
| Pentax of America, INC. | $99.21 | 2024 | Pentax Medical, Inspira, C2 Cryoballoon Focal Controller |
| Olympus America INC. | $98.86 | 2023 | Evis Exera III Gastrointestinal Videoscope |
| Novo Nordisk INC | $25.50 | 2025 | Wegovy |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvind Rangarajan Murali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.